Investors

Media Coverage

NASDAQ: ENVB

Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts

Media Coverage

Unlocking New Horizons: Enveric Biosciences’ Strategic Moves in Biotechnology [Microdose]

April 30, 2024

From LSD to healing minds: Where are we standing in psychedelic drug development? [Labiotech]

March 13, 2024

Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan [Endpoints News]

February 29, 2024

Dr. Joe Tucker, CEO of Enveric Biosciences [The Green Rush]

February 29, 2024

12 Health Care Stocks Moving In Thursday’s Pre-Market Session [Benzinga]

February 29, 2024

EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds [Benzinga]

February 29, 2024

Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments [Benzinga]

February 23, 2024

Enveric sells cannabis patents to focus on psilocin candidates [Green Market Report]

February 23, 2024

Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds [Benzinga]

February 21, 2024

Non-Hallucinogenic Psilocybin-Based Therapies Promote Neuroplasticity Show Promise Treating Mental Health Disorders with Joe Tucker Enveric Biosciences [Empowered Patient Podcast]

February 12, 2024

‹
1
…
7
8
9
10
11
…
17
›